methotrexate
Showing 26 - 50 of 944
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)
Recruiting
- Primary Central Nervous System Lymphoma
- +2 more
- Methotrexate
- +2 more
-
Guandong, Guangdong, China
- +2 more
Apr 6, 2022
Rheumatoid Arthritis Trial in Sweden (Methotrexate)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
-
Eskilstuna, Sweden
- +10 more
Jun 28, 2022
Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)
Active, not recruiting
- Arthritis, Juvenile
- Golimumab
- Methotrexate
-
San Diego, California
- +37 more
Jan 17, 2023
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,
Recruiting
- Lymphoblastic Leukemia
- +2 more
- Inotuzumab ozogamicin
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 16, 2022
Hypophosphatasia Trial (methotrexate, rituximab, bortezomib)
Not yet recruiting
- Hypophosphatasia
- methotrexate
- +4 more
- (no location specified)
Aug 23, 2023
Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)
Not yet recruiting
- Non-hodgkin Lymphoma
- Methotrexate
- +2 more
- (no location specified)
Aug 11, 2023
Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Takayasu Arteritis
- Tofacitinib
- Methotrexate
-
Shanghai, Shanghai, ChinaLindi Jiang
Oct 19, 2021
Uveitis Trial in Spain (Methotrexate, Adalimumab, Adalimumab+Methotrexate)
Recruiting
- Uveitis
- Methotrexate
- +2 more
-
A Coruña, Spain
- +13 more
Mar 15, 2022
ive Alzheimer's Medicines - Methotrexate vs Hydroxychloroquine
Completed
- Rheumatoid Arthritis
- Methotrexate
- Hydroxychloroquine
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021
Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)
Completed
- Psoriatic Arthritis
- Methotrexate
- +2 more
-
Frankfurt am Main, Hessia, GermanyCIRI
Mar 1, 2022
Low Dose Methotrexate in Severe Chronic Asthma Trial (Methotrexate, Placebo)
Not yet recruiting
- Low Dose Methotrexate in Severe Chronic Asthma
- Methotrexate
- Placebo
- (no location specified)
Sep 27, 2021
Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia (ALL) in Partial Remission
- +2 more
- Cyclophosphamide 50mg
- Methotrexate
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Center
Apr 4, 2022
Rates of Dementia and Alzheimer's Disease in Participants
Completed
- Dementia
- Alzheimer Disease
- Methotrexate
- Anti-TNF
-
Titusville, New JerseyJanssen R&D
Oct 15, 2021
GTD, Gestational Trophoblastic Neoplasia, Stage I GTD Trial in Beijing (Methotrexate, Leucovorin, Dactinomycin)
Recruiting
- Gestational Trophoblastic Tumor
- +6 more
- Methotrexate
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 14, 2021
Rheumatoid Arthritis, Rheumatic Diseases Trial in Leiden (Abatacept, Methotrexate)
Completed
- Rheumatoid Arthritis
- Rheumatic Diseases
- Abatacept
- Methotrexate
-
Leiden, NetherlandsLeiden University Medical Center
Aug 16, 2022
MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)
Recruiting
- Myelodysplastic Syndromes, de Novo
- +10 more
- Venetoclax
- +10 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 23, 2023
Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)
Completed
- Head and Neck Squamous Cell Cancer
- pembrolizumab
- +3 more
- (no location specified)
Aug 24, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Bone Scan
- +7 more
- (no location specified)
Jan 18, 2023
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,
Active, not recruiting
- Chronic Myelogenous Leukemia
- +9 more
- tacrolimus
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021
Acute GVH Disease Trial in Beijing (Methotrexate)
Recruiting
- Acute GVH Disease
- Methotrexate
-
Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
Sep 14, 2021